$SOLV News

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Solventum Receives FDA Clearance For Combined Use Of Restrata Synthetic Electrospun Fiber Matrix, Solventum V.A.C. Therapy

Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026

Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?

How Is Solventum's Stock Performance Compared to Other Healthcare Stocks

Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds

Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play

What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders

Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses

BTIG Reiterates Buy on Solventum, Maintains $95 Price Target

Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

Solventum (SOLV) Price Target Increased by 10.88% to 95.90

3 Reasons to Avoid SOLV and 1 Stock to Buy Instead

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum (SOLV) Q2 2026 Earnings Call Transcript

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans

Solventum Q2 Earnings Call Highlights

UBS Maintains Buy on Solventum, Raises Price Target to $101